The Journal of Urology
Volume 175, Issue 4 , Pages 1353-1358, April 2006

Efficacy and Safety of Histrelin Subdermal Implant in Patients With Advanced Prostate Cancer

  • Peter N. Schlegel

      Affiliations

    • Financial interest and/or other relationship with Valera Pharmaceuticals.
    • Corresponding Author InformationCorrespondence: Starr 900, Department of Urology, New York Presbyterian Hospital-Weill Cornell Medical Center, 525 East 68th St., New York, New York 10021 (telephone: 212-746-5491; FAX: 212-746-8425)
    • ,
  • Histrelin Study Group

Department of Urology, Weill Medical College of Cornell University, New York, New York

Received 15 December 2004

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Supported by a grant from Valera Pharmaceuticals.

PII: S0022-5347(05)00649-X

doi:10.1016/S0022-5347(05)00649-X

The Journal of Urology
Volume 175, Issue 4 , Pages 1353-1358, April 2006

Article Tools

* Image Usage & Resolution